Pavelka L, Rauschenberger A, Landoulsi Z, Pachchek S, May P, Glaab E, Krüger R
Clinical and Experimental Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Parkinson's Research Clinic, Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
NPJ Parkinsons Dis. 2022 Aug 9;8(1):102. doi: 10.1038/s41531-022-00342-7.
Several phenotypic differences observed in Parkinson's disease (PD) patients have been linked to age at onset (AAO). We endeavoured to find out whether these differences are due to the ageing process itself by using a combined dataset of idiopathic PD (n = 430) and healthy controls (HC; n = 556) excluding carriers of known PD-linked genetic mutations in both groups. We found several significant effects of AAO on motor and non-motor symptoms in PD, but when comparing the effects of age on these symptoms with HC (using age at assessment, AAA), only positive associations of AAA with burden of motor symptoms and cognitive impairment were significantly different between PD vs HC. Furthermore, we explored a potential effect of polygenic risk score (PRS) on clinical phenotype and identified a significant inverse correlation of AAO and PRS in PD. No significant association between PRS and severity of clinical symptoms was found. We conclude that the observed non-motor phenotypic differences in PD based on AAO are largely driven by the ageing process itself and not by a specific profile of neurodegeneration linked to AAO in the idiopathic PD patients.
在帕金森病(PD)患者中观察到的几种表型差异与发病年龄(AAO)有关。我们试图通过使用特发性PD患者(n = 430)和健康对照(HC;n = 556)的合并数据集来找出这些差异是否归因于衰老过程本身,两组均排除已知PD相关基因突变的携带者。我们发现AAO对PD患者的运动和非运动症状有几个显著影响,但在将年龄对这些症状的影响与HC进行比较时(使用评估时的年龄,AAA),仅AAA与运动症状负担和认知障碍的正相关在PD与HC之间存在显著差异。此外,我们探讨了多基因风险评分(PRS)对临床表型的潜在影响,并确定了PD患者中AAO与PRS之间存在显著的负相关。未发现PRS与临床症状严重程度之间存在显著关联。我们得出结论,基于AAO在PD中观察到的非运动表型差异在很大程度上是由衰老过程本身驱动的,而不是由特发性PD患者中与AAO相关的特定神经退行性变特征驱动的。